Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 6/2017

Open Access 01-09-2017 | IM - COMMENTARY

Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods

Authors: Riccardo Polosa, Pasquale Caponnetto, Ray Niaura, David Abrams

Published in: Internal and Emergency Medicine | Issue 6/2017

Login to get access

Excerpt

Smoking is a difficult addiction to break with many smokers persisting in tobacco use for numerous years, and typically cycling through multiple periods of remission and relapse [1]. Yet, while smoking cessation may be the most desirable final outcome, substitution of conventional cigarettes by alternative non-combusted forms of nicotine delivery, such as electronic cigarettes (ECs), is now a realistic compromise that is likely to eliminate or substantially reduce exposure to tobacco smoke toxicants [2]. …
Literature
1.
Caponnetto P, Keller E, Bruno CM, Polosa R (2013) Handling relapse in smoking cessation: strategies and recommendations. Intern Emerg Med 8:7–12CrossRefPubMed
2.
Polosa R, Rodu B, Caponnetto P, Maglia M, Raciti C (2013) A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 10:19CrossRefPubMedPubMedCentral
3.
Caponnetto P, Russo C, Bruno CM, Alamo A, Amaradio MD, Polosa R (2013) Electronic cigarette: a possible substitute for cigarettedependence. Monaldi Arch Chest Dis 79:12–19PubMed
4.
Farsalinos KE, Polosa R (2014) Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. TherAdv Drug Saf 5:67–86CrossRef
5.
Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D (2016) E-cigarettes are less harmful than smoking. Lancet 387(10024):1160–1162CrossRefPubMed
6.
Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC (2017) Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med 52(2):e33–e66CrossRefPubMed
7.
Giovenco DP, Lewis MJ, Delnevo CD (2014) Factors associated with e-cigarette use: a National Population Survey of Current and Former Smokers. Am J Prev Med 47(4):476–480CrossRefPubMedPubMedCentral
8.
Pearson JL, Stanton CA, Cha S, Niaura RS, Luta G, Graham AL (2015) E-cigarettes and smoking cessation: insights and cautions from a secondary analysis of data from a study of online treatment-seeking smokers. Nicotine Tob Res 17(10):1219–1227CrossRefPubMed
9.
Amato MS, Boyle RG, Levy D (2016) How to define e-cigarette prevalence? Finding clues in the use frequency distribution. Tob Control. 25(e1):e24–e29CrossRefPubMed
10.
Johnston LD, O’Malley PM, Miech RA, Bachman JG, Schulenberg JE (2016) Monitoring the future: national survey results on drug use 1975–2015—2015 overview: key findings on adolescent drug use. University of Michigan Institute for Social Research, Ann Arbor
11.
12.
13.
Biener L, Hargraves JL (2015) A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 17(2):127–133CrossRefPubMed
14.
Hitchman SC, Brose LS, Brown J, Robson D, McNeill A (2015) Associations between E-cigarette Type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res 17(10):1187–1194CrossRefPubMedPubMedCentral
15.
Pepper JK, Ribisl KM, Emery SL, Brewer NT (2014) Reasons for starting and stopping electronic cigarette use. Int J Environ Res Public Health 11(10):10345–10361CrossRefPubMedPubMedCentral
16.
Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V (2013) Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 7:139–146PubMedPubMedCentral
17.
Farsalinos KE, Poulas K, Voudris V, Le Houezec J (2017) Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey. Intern Emerg Med. doi:10.​1007/​s11739-017-1643-7 (epub ahead of print) PubMed
18.
Caponnetto P, Saitta D, Sweanor D, Polosa R (2015) What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. Int J Drug Policy. 26(6):554–559CrossRefPubMed
19.
Polosa R, Caponnetto P, Cibella F, Le-Houezec J (2015) Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int J Environ Res Public Health 12:3428–3438CrossRefPubMedPubMedCentral
20.
Caponnetto P, Maglia M, Polosa R, Commentary on Dawkins et al (2015) Electronic cigarettes—from smoking cessation to smoking sensation and back. Addiction 2015(110):678–679CrossRef
21.
Adriaens K, Van Gucht D, Declerck P, Baeyens F (2014) Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 11:11220–11248CrossRefPubMedPubMedCentral
Metadata
Title
Analysis of E-cigarette use in the 2014 Eurobarometer survey: calling out deficiencies in epidemiology methods
Authors
Riccardo Polosa
Pasquale Caponnetto
Ray Niaura
David Abrams
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 6/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1667-z

Other articles of this Issue 6/2017

Internal and Emergency Medicine 6/2017 Go to the issue

CE - Systematic Review

Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis

IM - ORIGINAL

Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population

EM - ORIGINAL

Are they trained? Prevalence, motivations and barriers to CPR training among cohabitants of patients with a coronary disease

IM - ORIGINAL

Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey

IM - CASE RECORD

Every cloud has a silver lining

IM - COMMENTARY

Exercise-mediated reactive oxygen species generation in athletes and in patients with chronic disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits